Immutep (IMMP) announces an upcoming poster presentation for the TACTI-004 Phase III trial. The poster will be presented at the European Lung ...

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer ...

India], March 11: Merck Foundation, the philanthropic arm of Merck KGaA Germany, together with First Ladies of Africa and ...

India], March 7: Merck Foundation, the philanthropic arm of Merck KGaA Germany together with First Ladies of Africa who are ...

Merck , known as MSD outside of the United States and Canada, today announced that new clinical and outcomes research data will be presented at the American College of Cardiology's Annual Scientific ...

Merck (NYSE:MRK) shares snaps six straight sessions ... arguing the “real culprit” behind the stock’s selloff since the recent earnings print is Keytruda’s loss of exclusivity in 2028.

Readers lament the self-censorship of public figures who fear retribution from the administration. Also: Remembering Selma; ...

Our Bureau, Mumbai Tuesday, March 18, 2025, 16:30 Hrs [IST] ...

PRT3789 has demonstrated clinical proof-of-concept that selectively degrading SMARCA2 is generally safe and has monotherapy anti-tumor activity ...

Critics warn against sweeping budget cuts that threaten jobs, clean energy and scientific progress. They fear lax regulatory ...